High serum granulocyte-colony stimulating factor characterises neutrophilic COPD exacerbations associated with dysbiosis

Arindam Chakrabarti, Jordan S. Mar, David F. Choy, Yi Cao, Nisha Rathore, Xiaoying Yang, Gaik W. Tew, Olga Li, Prescott G. Woodruff, Christopher E. Brightling, Michele Grimbaldeston, Stephanie A. Christenson, Mona Bafadhel, Carrie M. Rosenberger

Source: ERJ Open Res, 7 (3) 00836-2020; 10.1183/23120541.00836-2020
Journal Issue: July
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Arindam Chakrabarti, Jordan S. Mar, David F. Choy, Yi Cao, Nisha Rathore, Xiaoying Yang, Gaik W. Tew, Olga Li, Prescott G. Woodruff, Christopher E. Brightling, Michele Grimbaldeston, Stephanie A. Christenson, Mona Bafadhel, Carrie M. Rosenberger. High serum granulocyte-colony stimulating factor characterises neutrophilic COPD exacerbations associated with dysbiosis. ERJ Open Res, 7 (3) 00836-2020; 10.1183/23120541.00836-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Increased levels of epidermal growth factor in sputum of smoking chronic bronchitis patients
Source: Eur Respir J 2003; 22: Suppl. 45, 178s
Year: 2003

Airway G-CSF identifies neutrophilic inflammation and contributes to asthma progression
Source: Eur Respir J, 55 (2) 1900827; 10.1183/13993003.00827-2019
Year: 2020



COPD exacerbations: is eosinophilia a protective factor?
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019

Increased serum IL-17 is an independent risk factor for severe asthma
Source: Annual Congress 2008 - Severe asthma: a heterogeneous clinical entity
Year: 2008



Serum interleukin-6 levels correlate with malnutrition in patients with acute exacerbation of COPD
Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease
Year: 2009


Upregulation of basic fibroblast growth factor in smokers with chronic bronchitis
Source: Eur Respir J 2006; 27: 957-963
Year: 2006



Association of genetic variations in the CSF2 and CSF3 genes with lung function in smoking-induced COPD
Source: Eur Respir J 2008; 32: 25-34
Year: 2008



Vascular endothelial growth factor (VEGF) levels in induced sputum and plasma in asymptomatic and COPD smokers. Correlation with airway and systemic inflammation
Source: Eur Respir J 2006; 28: Suppl. 50, 652s
Year: 2006

Increased vascular endothelial growth factor in acute eosinophilic pneumonia
Source: Eur Respir J 2003; 21: 774-778
Year: 2003



Serum Interleukin (IL)-6 levels in patients with severe asthma disease is associated with blood eosinophilia
Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD
Year: 2020


Change of induced sputum TNF-a and sTNF-R55,75 levels in patients with acute exacerbations of COPD
Source: Annual Congress 2007 - Respiratory pathophysiology
Year: 2007


Serum TNFα and IL8 as markers of systemic inflammation in severe asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 279s
Year: 2005

Imbalance in the oral bacterial flora as a risk factor for acute exacerbation in idiopathic pulmonary fibrosis
Source: International Congress 2019 – The evolving field of idiopathic interstitial pneumonia
Year: 2019




Hepatocyte growth factor – a link between neutrophilic inflammation and BOS?
Source: Eur Respir J 2006; 28: Suppl. 50, 120s
Year: 2006

Sputum VEGF level increases with treatment of COPD acute exacerbation
Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation
Year: 2012


Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016

COPD exacerbation severity is associated with impaired macrophage phagocytosis of eosinophils
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013


Increased serum endotoxin levels as biomarker in acute exacerbations of COPD.
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018

Surges in circulating interleukin-6 and transforming growth factor-β associated with exercise in patients with COPD are attenuated by pulmonary rehabilitation
Source: Annual Congress 2009 - Exploring outcome measures in COPD and pulmonary rehabilitation
Year: 2009


Effects of platelet-activating factor (PAF) challenge on airway neutrophilia and adhesion molecules in mild asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 163s
Year: 2001